Medicaid Drug Price Initiative: One Year Mark Reached

One year has passed since an initiative to lower certain Medicaid prescription drug prices was announced. The agreement, presented as a voluntary measure, involved commitments from pharmaceutical companies.

On September 30, a pharmaceutical executive joined administration officials at the White House for the announcement. A primary component of this initiative focused on reducing costs within the Medicaid program.

However, the program is still under development. Specific drugs that will receive discounts remain undisclosed. Additionally, individual states must opt into the program for its provisions to take effect within their borders.